Package 51662-1601-1

Brand: glycopyrrolate

Generic: glycopyrrolate
NDC Package

Package Facts

Identity

Package NDC 51662-1601-1
Digits Only 5166216011
Product NDC 51662-1601
Product ID 51662-1601_0f926dfb-69bc-4d9f-e063-6394a90a1e71
Description

5 mL in 1 VIAL (51662-1601-1)

Marketing

Marketing Status
Marketed Since 2022-08-29
Brand glycopyrrolate
Generic glycopyrrolate
Sample Package No

Linked Drug Pages (1)

GLYCOPYRROLATE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "0f926dfb-69bc-4d9f-e063-6394a90a1e71", "openfda": {"unii": ["V92SO9WP2I"], "rxcui": ["238212"], "spl_set_id": ["e76bc0e4-68f5-70b4-e053-2a95a90a451e"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "5 mL in 1 VIAL (51662-1601-1)", "package_ndc": "51662-1601-1", "marketing_start_date": "20220829"}, {"sample": false, "description": "25 POUCH in 1 CASE (51662-1601-3)  / 1 VIAL in 1 POUCH (51662-1601-2)  / 5 mL in 1 VIAL", "package_ndc": "51662-1601-3", "marketing_start_date": "20230119"}], "brand_name": "GLYCOPYRROLATE", "product_id": "51662-1601_0f926dfb-69bc-4d9f-e063-6394a90a1e71", "dosage_form": "INJECTION", "pharm_class": ["Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]", "Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "51662-1601", "generic_name": "GLYCOPYRROLATE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GLYCOPYRROLATE", "active_ingredients": [{"name": "GLYCOPYRROLATE", "strength": ".2 mg/mL"}], "application_number": "ANDA090963", "marketing_category": "ANDA", "marketing_start_date": "20220829", "listing_expiration_date": "20261231"}